O slideshow foi denunciado.
Utilizamos seu perfil e dados de atividades no LinkedIn para personalizar e exibir anúncios mais relevantes. Altere suas preferências de anúncios quando desejar.

20150924 smb biosenz johan oosterheert

445 visualizações

Publicada em

Presentation Science Meets Business @Health Valley From Molecule to Business 20150924

Publicada em: Saúde e medicina
  • Seja o primeiro a comentar

  • Seja a primeira pessoa a gostar disto

20150924 smb biosenz johan oosterheert

  1. 1. Biosenz B.V. – A Lavoisier Company - Zernikepark 16 9747AN Groningen – 050 8508960- info@biosenz.nl - www.biosenz.nl ViriChip™ System: A platform technology for virus detection and identification Johan Oosterheert, Managing director September 24, 2015
  2. 2. 9/28/2015 Strictly confidential New 'Sars-like' coronavirus identified by UK officials By Michelle Roberts Health editor, BBC News online, September 2012 A new respiratory illness similar to the Sars virus that spread globally in 2003 and killed hundreds of people has been identified in a man who is being treated in Britain. The 49-year-old man, who was transferred to a London hospital by air ambulance from Qatar, is the second person confirmed with the corona virus. The first case was a patient in Saudi Arabia who has since died. Officials are still determining what threat the new virus may pose. Infectious viruses pose a serious threat to public health • Current diagnostic systems for viruses use central labs • Identification may take several days
  3. 3. ViriChip™ shortens response time dramatically 9/28/2015 Strictly confidential The ViriChip™ System brings the Lab to the field! The ViriChip™ System: • Size of a shoe box • On-the-spot detection and identification • 30 minutes response time
  4. 4. ViriChip™ is a unique, patented lab-on-a chip technology 9/28/2015 Strictly confidential Nano - and Biotechnology Atomic Force Microscopy Ligand capture Biosenz holds exclusive world-wide license on several patents
  5. 5. Biosenz has validated the technology 9/28/2015 Strictly confidential Silicon chip including antibodies with Coxsackie B3 virus attached Biosenz has validated 15 different viruses
  6. 6. ViriChip offers sensitivity, specificity, ease of use and speed 9/28/2015 Strictly confidential ViriChip PCR Immuno assays Immuno electron Microscopy Cell culture RAMP Response time Integral cost/test Sensitivity Specificity Portability Ease of use Bulk processing
  7. 7. Biosenz intends to sell Virichip in multiple markets 9/28/2015 Strictly confidential 1 2 3 4 5 6 7 8 Veterinary Food Clinical Markets CDC, Homeland Security, Defense Research Institutes US Bio-defense busget $ 6.4 Bln. In 2012 World In-vitro diagnostic market $ 40 Bln. (2010) POCT for infectious diseases $ 843 M (2011); 14% CAGR
  8. 8. Biosenz operates as a network organization 9/28/2015 Strictly confidential
  9. 9. ViriChip presents a unique opportunity • Current diagnostic methods used to identify viruses use central labs and take days • ViriChip technology brings the lab to the field, reducing response time to ~30 minutes • Significant market potential • Limited risk through business model and team 9/28/2015 Strictly confidential
  10. 10. Thank you for your attention. 9/28/2015 Strictly confidential

×